Case Study
Transforming trial design and positioning for novel oncology therapy
Client Challenge
A European based international oncology biotech company asked us to develop the business case for launch indications in the US and EU-5 for a novel oncology therapy in Phase I/II. They also needed to prioritise and value their follow-on clinical development indications.